Matthew Leming, Ph.D.
As Innovation Analyst, Matthew primarily supports resident companies of the TMCx Accelerator program to grow and support the entrepreneurial efforts of these health care focused startups.
He has 10 years of experience in basic science research with 11 peer reviewed publications, complimented by more than five years of experience with project/program management and technology transfer. Matthew has a breadth of experience in commercialization projects ranging from academic to commercial translation, mobile health platforms, medical devices, and drug discovery.
Matthew received his B.S. in Genetics from the University of Kansas in 2007 and a Ph.D. in Biology from the University of Notre Dame in 2015 and subsequently served as a Postdoctoral Associate at Children’s Hospital of Pittsburgh of UPMC, where he began working in translational science and commercialization. However, his passion truly lies in the field of medical device commercialization.